寛解期の炎症性腸疾患における恐怖誘発性痛覚過敏
Hanna Öhlmann1, Liubov Rohde1, Jost Langhorst2,3
1Department of Medical Psychology and Medical Sociology, Center of Medical Psychology and Translational Neuroscience, Medical Faculty, Ruhr University Bochum, Bochum, Germany.
Pain
|February 6, 2026
まとめ
寛解期の炎症性腸疾患(IBD)患者は、恐怖学習と関連した痛覚過敏を示す。この条件付けられた恐怖を標的とすることで、IBDにおける持続的疼痛の軽減につながる可能性があり、重要な治療ギャップに対処するものである。
科学分野:
- 神経科学
- 消化器病学
- 心理学
背景:
- 持続的疼痛は、活動性の腸管炎症がない場合でも、炎症性腸疾患(IBD)で一般的である。
- この慢性疼痛のメカニズムは完全には解明されていないが、疼痛に対する情動反応の変化が疑われている。
- IBDにおける疼痛持続に対する恐怖学習の関連性を示す実験的証拠は限られている。
研究 の 目的:
- 寛解期のIBD患者において、疼痛関連恐怖学習が急性実験的疼痛の知覚に影響を与えるかどうかを調査すること。
- IBD患者における恐怖条件付けと消去を健常対照群と比較して評価すること。
- IBDにおける疼痛持続における情動反応の役割を探求すること。
主な方法:
- 2日間の弁別的恐怖条件付けパラダイムを使用した。
- 参加者には、寛解期のIBD患者および健常対照群が含まれた。
- 恐怖の獲得と消去は、熱痛および不快なトーンを刺激として使用し、その後、疼痛強度と不快感の再評価を行った。
主要な成果:
- 寛解期のIBD患者は、対照群と比較して、疼痛への再曝露時に有意に高い疼痛強度と不快感を報告した。
- この増強された疼痛知覚は、疼痛関連恐怖学習の程度と相関していた。
- 恐怖の獲得と消去の行動は、両群間で同様であり、誇張された恐怖学習ではなく中枢性の適応を示唆していた。
結論:
- 恐怖誘発性痛覚過敏は、IBDにおける持続的疼痛に寄与する中枢メカニズムである可能性がある。
- 疼痛の不快感が、恐怖学習と疼痛強度との関係を完全に媒介し、情動価の役割を強調した。
- 条件付けられた恐怖反応を標的とすることは、IBD関連疼痛を管理するための個別化介入の重要な戦略となり得る。
さらに関連する動画
関連する概念動画
Inflammatory Bowel Disease II: Crohn's Disease
1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Inflammatory Bowel Disease I: Ulcerative Colitis
1.0K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.0K
Inflammatory Bowel Disease V: Surgical Management
557
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
557
Inflammatory Bowel Disease IV: Pharmacological Management
646
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
646
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
766
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
766
Inflammatory Response
16.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.8K


